NYB, Sweetch Group team up on AI-driven beauty ingredient discovery

Nanyang Biologics and Sweetch Group, through Laboratoire GreenPharma, have formed a strategic collaboration to speed discovery of nature-derived bioactive ingredients for skincare and cosmetics. The partnership pairs phytochemistry, green chemistry and agentic AI to identify promising molecules faster and move them toward market-ready ingredients.

Why it matters: - The collaboration targets faster discovery of scientifically validated, nature-derived ingredients for skincare and cosmetics. - The effort could shorten the path from early screening to market-ready bioactive ingredients. - The partnership also opens a path to future work in consumer health, where demand for nature-derived bioactives is growing.

What happened: - Nanyang Biologics announced a strategic collaboration with Sweetch Group, through its subsidiary Laboratoire GreenPharma, on July 14, 2026, in Singapore. - The companies will work together to accelerate discovery and development of next-generation nature-derived bioactive ingredients for skincare and cosmetics. - The collaboration combines Laboratoire GreenPharma’s phytochemistry, natural compounds, chemoinformatics and ingredient discovery work with NYB’s agentic AI platform Vecura for bioactivity prediction. - Sweetch Group contributes capabilities in developing and commercializing high-performance bio-based ingredients through natural products, biotechnologies and green chemistry.

The details: - The collaboration is designed to improve speed, precision and scientific validation in ingredient discovery. - The companies aim to identify and prioritize the most promising bioactive molecules. - The model is intended to move those molecules more efficiently from discovery into commercial ingredients. - NYB and Sweetch Group say their combined ecosystem spans more than 210,000 organisms. - The broader platform covers natural compound research, AI-powered molecular discovery, green chemistry, ingredient development and commercialization. - NYB develops discovery platforms including Vecura and the Vecurate library across pharmaceuticals, consumer health and cosmeceuticals. - Sweetch Group develops and delivers bio-based ingredients for beauty through proprietary technologies rooted in natural products and green chemistry. - Laboratoire GreenPharma specializes in natural substances, active ingredient discovery, extraction, structural identification, chemoinformatics and formulation support for cosmetic, pharmaceutical and agro-food industries.

Between the lines: - The partnership reflects a push to combine biological knowledge with AI to reduce guesswork in ingredient discovery. - The emphasis on sustainability and green chemistry suggests brands are looking for cleaner, science-backed ingredient pipelines. - The scale of the organism library signals an attempt to build a broad sourcing advantage, not just a single-product program.

What's next: - The collaboration will initially focus on skincare and cosmetics. - Future expansion into consumer health remains under consideration. - The companies will work to uncover differentiated ingredients with stronger scientific rationale and greater efficiency. - The partnership is expected to advance high-performance, bio-based ingredients toward commercialization.